[Treatment of primary liver cancer associated with active hepatitis].
Zuo
Chao-hui
CH
Ou Yang
Yong-zhong
YZ
Mo
Sheng-chuan
SC
D000328:Adult; D000368:Aged; D006528:Carcinoma, Hepatocellular / Q000601:surgery* / Q000821:virology; D005260:Female; D005500:Follow-Up Studies; D005978:Glutathione / Q000627:therapeutic use; D006498:Hepatectomy / Q000379:methods; D006509:Hepatitis B / Q000097:blood / Q000188:drug therapy*; D006514:Hepatitis B Surface Antigens / Q000097:blood; D006526:Hepatitis C / Q000188:drug therapy; D006801:Humans; D008113:Liver Neoplasms / Q000601:surgery* / Q000821:virology; D008297:Male; D008875:Middle Aged; D011379:Prognosis
D006514:Hepatitis B Surface Antigens; D005978:Glutathione